UPDATE: Jazz Pharmaceuticals (JAZZ) PT Raised to $209 as Jefferies Finds GWPH more Accretive Than Anticipated
Tweet Send to a Friend
(Updated - February 16, 2021 7:56 AM EST)
Jefferies analyst David Steinberg raised the price target on Jazz Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst David Steinberg raised the price target on Jazz Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


